Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)
$5.44
-0.4500 ( -7.64% ) 573.5K
BiondVax Pharmaceuticals Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline.
Market Data
Open
$5.44
Previous close
$5.89
Volume
573.5K
Market cap
$4.65M
Day range
$4.95 - $5.80
52 week range
$2.23 - $13.70
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
20-f | Annual reports | 92 | May 15, 2024 |
6-k | Quarterly Reports | 2 | May 07, 2024 |
nt | Quarterly Reports | 1 | Apr 30, 2024 |
6-k | Quarterly Reports | 47 | Apr 25, 2024 |
6-k | Quarterly Reports | 44 | Apr 16, 2024 |
6-k | Quarterly Reports | 35 | Jan 18, 2024 |
6-k | Quarterly Reports | 35 | Jan 09, 2024 |
6-k | Quarterly Reports | 3 | Jan 04, 2024 |
6-k | Quarterly Reports | 4 | Jan 02, 2024 |
6-k | Quarterly Reports | 2 | Jan 02, 2024 |